Current and historical daily PE Ratio for Claritas Pharmaceuticals Inc (
) from 2007 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Claritas Pharmaceuticals stock (FRA:S6VA) PE ratio as of Apr 26 2024 is 0.
More Details
Claritas Pharmaceuticals Inc (FRA:S6VA) PE Ratio (TTM) Chart
Claritas Pharmaceuticals Inc (FRA:S6VA) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 811
- 1
- 2
- 3
- 4
- 5
- 6
- 10
| Claritas Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2022-12-12 | At Loss | 2022-06-15 | At Loss |
| 2022-12-09 | At Loss | 2022-06-14 | At Loss |
| 2022-12-08 | At Loss | 2022-06-13 | At Loss |
| 2022-12-07 | At Loss | 2022-06-10 | At Loss |
| 2022-12-06 | At Loss | 2022-06-09 | At Loss |
| 2022-12-05 | At Loss | 2022-06-08 | At Loss |
| 2022-12-02 | At Loss | 2022-06-07 | At Loss |
| 2022-12-01 | At Loss | 2022-06-06 | At Loss |
| 2022-11-30 | At Loss | 2022-06-03 | At Loss |
| 2022-11-29 | At Loss | 2022-06-02 | At Loss |
| 2022-11-28 | At Loss | 2022-06-01 | At Loss |
| 2022-11-25 | At Loss | 2022-05-30 | At Loss |
| 2022-11-24 | At Loss | 2022-05-27 | At Loss |
| 2022-11-23 | At Loss | 2022-05-26 | At Loss |
| 2022-11-22 | At Loss | 2022-05-25 | At Loss |
| 2022-07-29 | At Loss | 2022-05-24 | At Loss |
| 2022-07-28 | At Loss | 2022-05-23 | At Loss |
| 2022-07-27 | At Loss | 2022-05-20 | At Loss |
| 2022-07-26 | At Loss | 2022-05-19 | At Loss |
| 2022-07-25 | At Loss | 2022-05-18 | At Loss |
| 2022-07-22 | At Loss | 2022-05-17 | At Loss |
| 2022-07-21 | At Loss | 2022-05-16 | At Loss |
| 2022-07-20 | At Loss | 2022-05-13 | At Loss |
| 2022-07-19 | At Loss | 2022-05-12 | At Loss |
| 2022-07-18 | At Loss | 2022-05-11 | At Loss |
| 2022-07-15 | At Loss | 2022-05-10 | At Loss |
| 2022-07-14 | At Loss | 2022-05-09 | At Loss |
| 2022-07-13 | At Loss | 2022-05-06 | At Loss |
| 2022-07-12 | At Loss | 2022-05-05 | At Loss |
| 2022-07-11 | At Loss | 2022-05-04 | At Loss |
| 2022-07-08 | At Loss | 2022-05-03 | At Loss |
| 2022-07-07 | At Loss | 2022-05-02 | At Loss |
| 2022-07-06 | At Loss | 2022-04-29 | At Loss |
| 2022-07-05 | At Loss | 2022-04-28 | At Loss |
| 2022-07-04 | At Loss | 2022-04-27 | At Loss |
| 2022-07-01 | At Loss | 2022-04-26 | At Loss |
| 2022-06-29 | At Loss | 2022-04-25 | At Loss |
| 2022-06-28 | At Loss | 2022-04-22 | At Loss |
| 2022-06-27 | At Loss | 2022-04-21 | At Loss |
| 2022-06-24 | At Loss | 2022-04-20 | At Loss |
| 2022-06-23 | At Loss | 2022-04-19 | At Loss |
| 2022-06-21 | At Loss | 2022-04-14 | At Loss |
| 2022-06-20 | At Loss | 2022-04-13 | At Loss |
| 2022-06-17 | At Loss | 2022-04-12 | At Loss |
| 2022-06-16 | At Loss | 2022-04-11 | At Loss |
Claritas Pharmaceuticals Inc (FRA:S6VA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Claritas Pharmaceuticals Inc
NAICS : 325412
SIC : 3799
ISIN : CA48349P1036
Description
Claritas Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company developing a portfolio of pharmaceutical products in Canada. It develops new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing, and delivering human therapeutics.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers